Please enable JavaScript to continue using this application.

Compare $ACRV vs $ICCC | Chartloom

Compare

$ACRV vs $ICCC

Acrivon Therapeutics Inc · ImmuCell Corp

ACRV

Acrivon Therapeutics Inc

ICCC

ImmuCell Corp

Compare $ACRV vs $ICCC

Comparing Acrivon Therapeutics Inc and ImmuCell Corp

ACRVAcrivon Therapeutics Inc

ICCCImmuCell Corp

ACRVAcrivon Therapeutics Inc

Market cap

$82M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.4%

52W performance

1.6%

FCF yield

-78.5%

ICCCImmuCell Corp

Market cap

$89M

P/E (TTM)

114.37x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

8.5%

YTD performance

65.5%

52W performance

48.7%

FCF yield

4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACRV

ICCC

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

ICCC

ImmuCell Corp

Market Cap

ACRV$82M

ICCC$89M

Enterprise Value

ACRV$40M

ICCC$88M

Price

ACRV$1.91

ICCC$9.80

P/E Ratio

ACRVN/A

ICCC114.37x

P/S Ratio

ACRV0.00x

ICCC2.89x

EV/Sales

ACRV0.00x

ICCC2.87x

EV/EBITDA

ACRV0.00x

ICCC14.10x

P/B Ratio

ACRV0.98x

ICCC2.82x

P/FCF Ratio

ACRVN/A

ICCC21.04x

EV/FCF

ACRV-0.63x

ICCC20.91x

PEG Ratio

ACRVN/A

ICCCN/A

Forward P/E (NTM)

ACRVN/A

ICCCN/A

Forward P/S (NTM)

ACRVN/A

ICCCN/A

Revenue (TTM)

ACRV$0

ICCC$31M

Revenue Growth (YoY)

ACRVN/A

ICCC8.5%

Forward Rev Growth

ACRV406.9%

ICCC0.0%

Gross Margin (TTM)

ACRV0.0%

ICCC40.3%

Operating Margin (TTM)

ACRV0.0%

ICCC3.9%

EBITDA Margin (TTM)

ACRV0.0%

ICCC20.4%

Net Margin (TTM)

ACRV0.0%

ICCC2.6%

FCF Margin (TTM)

ACRVN/A

ICCC13.7%

Net Income (TTM)

ACRV$-74M

ICCC$787K

FCF (TTM)

ACRV$-64M

ICCC$4M

EPS (TTM)

ACRV-$1.77

ICCC$0.09

ROE (TTM)

ACRV-7014.0%

ICCC2.7%

ROA (TTM)

ACRV-6161.0%

ICCC1.8%

ROIC (TTM)

ACRV-7014.0%

ICCC2.1%

Cash

ACRV$41M

ICCC$9M

Debt

ACRV$0

ICCC$8M

Net Cash/Debt

ACRV$41M

ICCC$557K

Current Ratio (TTM)

ACRV7.99x

ICCC4.75x

Quick Ratio (TTM)

ACRV7.86x

ICCC2.65x

Debt/Equity (TTM)

ACRV0.00x

ICCC0.26x

Debt/Assets (TTM)

ACRV0.0%

ICCC0.0%

Interest Coverage (TTM)

ACRVN/A

ICCCN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

ICCC0.00x

Beta

ACRV1.95

ICCC0.60

52W Performance

ACRV1.6%

ICCC48.7%

YTD Performance

ACRV-22.4%

ICCC65.5%

% from 52W High

ACRV-46.3%

ICCC-19.0%

% from 52W Low

ACRV50.4%

ICCC116.8%

Asset Turnover (TTM)

ACRV0.00x

ICCC0.69x

FCF Yield (TTM)

ACRV-78.5%

ICCC4.8%

Earnings Yield (TTM)

ACRV-90.8%

ICCC0.9%

Dividend Yield (TTM)

ACRVN/A

ICCCN/A

Rule of 40

ACRV0.0

ICCC22.2

EV/GP/RG

ACRVN/A

ICCCN/A

Ticker research

View ACRV research View ICCC research

Metric	ACRV Acrivon Therapeutics Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$82M	$89M
Enterprise Value	$40M	$88M
Price	$1.91	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	0.00x	2.89x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	0.98x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-0.63x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	406.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	0.0%	20.4%
Net Margin (TTM)	0.0%	2.6%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-74M	$787K
FCF (TTM)	$-64M	$4M
EPS (TTM)	-$1.77	$0.09
ROE (TTM)	-7014.0%	2.7%
ROA (TTM)	-6161.0%	1.8%
ROIC (TTM)	-7014.0%	2.1%
Financial Health
Cash	$41M	$9M
Debt	$0	$8M
Net Cash/Debt	$41M	$557K
Current Ratio (TTM)	7.99x	4.75x
Quick Ratio (TTM)	7.86x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.60
52W Performance	1.6%	48.7%
YTD Performance	-22.4%	65.5%
% from 52W High	-46.3%	-19.0%
% from 52W Low	50.4%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-78.5%	4.8%
Earnings Yield (TTM)	-90.8%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	22.2
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View ICCC research

Valuation

P/E Ratio

ICCC

114.37x

P/S Ratio

ACRV

0.00x

ICCC

2.89x

EV/FCF

ACRV

-0.63x

ICCC

20.91x

Growth & revenue

Revenue Growth TTM

ICCC

8.5%

Forward Revenue Growth

ACRV

406.9%

ICCC

0.0%

Profitability & performance

Gross Margin

ICCC

40.3%

ACRV

0.0%

ROE

ICCC

2.7%

ACRV

-7014.0%

FCF Yield %

ICCC

4.8%

ACRV

-78.5%

52-Week Performance

ICCC

48.7%

ACRV

1.6%

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

ICCC

ImmuCell Corp

Market Cap

ACRV$82M

ICCC$89M

Enterprise Value

ACRV$40M

ICCC$88M

Price

ACRV$1.91

ICCC$9.80

P/E Ratio

ACRVN/A

ICCC114.37x

P/S Ratio

ACRV0.00x

ICCC2.89x

EV/Sales

ACRV0.00x

ICCC2.87x

EV/EBITDA

ACRV0.00x

ICCC14.10x

P/B Ratio

ACRV0.98x

ICCC2.82x

P/FCF Ratio

ACRVN/A

ICCC21.04x

EV/FCF

ACRV-0.63x

ICCC20.91x

PEG Ratio

ACRVN/A

ICCCN/A

Forward P/E (NTM)

ACRVN/A

ICCCN/A

Forward P/S (NTM)

ACRVN/A

ICCCN/A

Revenue (TTM)

ACRV$0

ICCC$31M

Revenue Growth (YoY)

ACRVN/A

ICCC8.5%

Forward Rev Growth

ACRV406.9%

ICCC0.0%

Gross Margin (TTM)

ACRV0.0%

ICCC40.3%

Operating Margin (TTM)

ACRV0.0%

ICCC3.9%

EBITDA Margin (TTM)

ACRV0.0%

ICCC20.4%

Net Margin (TTM)

ACRV0.0%

ICCC2.6%

FCF Margin (TTM)

ACRVN/A

ICCC13.7%

Net Income (TTM)

ACRV$-74M

ICCC$787K

FCF (TTM)

ACRV$-64M

ICCC$4M

EPS (TTM)

ACRV-$1.77

ICCC$0.09

ROE (TTM)

ACRV-7014.0%

ICCC2.7%

ROA (TTM)

ACRV-6161.0%

ICCC1.8%

ROIC (TTM)

ACRV-7014.0%

ICCC2.1%

Cash

ACRV$41M

ICCC$9M

Debt

ACRV$0

ICCC$8M

Net Cash/Debt

ACRV$41M

ICCC$557K

Current Ratio (TTM)

ACRV7.99x

ICCC4.75x

Quick Ratio (TTM)

ACRV7.86x

ICCC2.65x

Debt/Equity (TTM)

ACRV0.00x

ICCC0.26x

Debt/Assets (TTM)

ACRV0.0%

ICCC0.0%

Interest Coverage (TTM)

ACRVN/A

ICCCN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

ICCC0.00x

Beta

ACRV1.95

ICCC0.60

52W Performance

ACRV1.6%

ICCC48.7%

YTD Performance

ACRV-22.4%

ICCC65.5%

% from 52W High

ACRV-46.3%

ICCC-19.0%

% from 52W Low

ACRV50.4%

ICCC116.8%

Asset Turnover (TTM)

ACRV0.00x

ICCC0.69x

FCF Yield (TTM)

ACRV-78.5%

ICCC4.8%

Earnings Yield (TTM)

ACRV-90.8%

ICCC0.9%

Dividend Yield (TTM)

ACRVN/A

ICCCN/A

Rule of 40

ACRV0.0

ICCC22.2

EV/GP/RG

ACRVN/A

ICCCN/A

Ticker research

View ACRV research View ICCC research

Metric	ACRV Acrivon Therapeutics Inc	ICCC ImmuCell Corp
Market & Valuation
Market Cap	$82M	$89M
Enterprise Value	$40M	$88M
Price	$1.91	$9.80
P/E Ratio	N/A	114.37x
P/S Ratio	0.00x	2.89x
EV/Sales	0.00x	2.87x
EV/EBITDA	0.00x	14.10x
P/B Ratio	0.98x	2.82x
P/FCF Ratio	N/A	21.04x
EV/FCF	-0.63x	20.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$31M
Revenue Growth (YoY)	N/A	8.5%
Forward Rev Growth	406.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	40.3%
Operating Margin (TTM)	0.0%	3.9%
EBITDA Margin (TTM)	0.0%	20.4%
Net Margin (TTM)	0.0%	2.6%
FCF Margin (TTM)	N/A	13.7%
Net Income (TTM)	$-74M	$787K
FCF (TTM)	$-64M	$4M
EPS (TTM)	-$1.77	$0.09
ROE (TTM)	-7014.0%	2.7%
ROA (TTM)	-6161.0%	1.8%
ROIC (TTM)	-7014.0%	2.1%
Financial Health
Cash	$41M	$9M
Debt	$0	$8M
Net Cash/Debt	$41M	$557K
Current Ratio (TTM)	7.99x	4.75x
Quick Ratio (TTM)	7.86x	2.65x
Debt/Equity (TTM)	0.00x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.60
52W Performance	1.6%	48.7%
YTD Performance	-22.4%	65.5%
% from 52W High	-46.3%	-19.0%
% from 52W Low	50.4%	116.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.69x
FCF Yield (TTM)	-78.5%	4.8%
Earnings Yield (TTM)	-90.8%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	22.2
EV/GP/RG	N/A	N/A
Ticker research	View ACRV research	View ICCC research